Vericel Corporation (VCEL)
NASDAQ: VCEL · IEX Real-Time Price · USD
46.05
+0.60 (1.32%)
At close: Apr 26, 2024, 4:00 PM
45.78
-0.27 (-0.59%)
After-hours: Apr 26, 2024, 5:33 PM EDT
Vericel Employees
Vericel had 314 employees on December 31, 2023. The number of employees increased by 9 or 2.95% compared to the previous year.
Employees
314
Change (1Y)
9
Growth (1Y)
2.95%
Revenue / Employee
$629,032
Profits / Employee
-$10,134
Market Cap
2.23B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 314 | 9 | 2.95% |
Dec 31, 2022 | 305 | 24 | 8.54% |
Dec 31, 2021 | 281 | 8 | 2.93% |
Dec 31, 2020 | 273 | 32 | 13.28% |
Dec 31, 2019 | 241 | 25 | 11.57% |
Dec 31, 2018 | 216 | 11 | 5.37% |
Dec 31, 2017 | 205 | 3 | 1.49% |
Dec 31, 2016 | 202 | 12 | 6.32% |
Dec 31, 2015 | 190 | 0 | - |
Dec 31, 2014 | 190 | 150 | 375.00% |
Dec 31, 2013 | 40 | -37 | -48.05% |
Dec 31, 2012 | 77 | 6 | 8.45% |
Dec 31, 2011 | 71 | 26 | 57.78% |
Jun 30, 2010 | 45 | -3 | -6.25% |
Jun 30, 2009 | 48 | 3 | 6.67% |
Jun 30, 2008 | 45 | -22 | -32.84% |
Jun 30, 2007 | 67 | 8 | 13.56% |
Jun 30, 2006 | 59 | 10 | 20.41% |
Jun 30, 2005 | 49 | -1 | -2.00% |
Jun 30, 2004 | 50 | 6 | 13.64% |
Jun 30, 2003 | 44 | 0 | - |
Jun 30, 2002 | 44 | 4 | 10.00% |
Jun 30, 2001 | 40 | 10 | 33.33% |
Jun 30, 2000 | 30 | -26 | -46.43% |
Aug 31, 1999 | 56 | -31 | -35.63% |
Aug 31, 1998 | 87 | 15 | 20.83% |
Jun 30, 1997 | 72 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Teladoc Health | 5,600 |
Integra LifeSciences Holdings | 3,946 |
Tandem Diabetes Care | 2,400 |
Guardant Health | 1,779 |
Inari Medical | 1,300 |
Arvinas | 445 |
Denali Therapeutics | 445 |
VCEL News
- 3 days ago - Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 2 months ago - Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance - GlobeNewsWire
- 2 months ago - Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 - GlobeNewsWire
- 2 months ago - Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024 - GlobeNewsWire
- 2 months ago - Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024 - GlobeNewsWire
- 3 months ago - Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results - GlobeNewsWire
- 4 months ago - Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024 - GlobeNewsWire
- 6 months ago - Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance - GlobeNewsWire